Biomarker discovery in subclinical mycobacterial infections of cattle

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Seth, Meetu ^a   Lamont, Elise A ^a   Janagama, Harish K ^a   Widdel, Andrea ^a   Vulchanova, Lucy ^a   Stabel, Judith R ^b   Waters, W Ray ^b   Palmer, Mitchell V ^b   Sreevatsan, Srinand ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; ALPHA 1B GLYCOPROTEIN; BIKUNIN PRECURSOR PROTEIN; BIOLOGICAL MARKER; CATHELICIDIN; FETUIN; OROSOMUCOID; PREALBUMIN; RETINOL BINDING PROTEIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN PRECURSOR; PLASMA PROTEIN; VITAMIN D BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE TUBERCULOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PATHOGENESIS; PEPTIDOMICS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; STRAIN DIFFERENCE; VACCINATION; ANIMAL; BLOOD; CATTLE; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROBIOLOGY; PHYSIOLOGY; REPRODUCIBILITY;

ANIMALIA; BOS; BOVINAE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; MYCOBACTERIUM BOVIS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CATTLE; CHROMATOGRAPHY, LIQUID; ISOTOPE LABELING; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; MYCOBACTERIUM BOVIS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUBERCULOSIS, BOVINE; VITAMIN D-BINDING PROTEIN;

EID: 65549154366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005478     Document Type: Article

References (34)

1. Cosivi O, Grange JM, Daborn CJ, Raviglione MC, Fujikura T, et al. (1998) Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 4: 59-70.
2. Evans JT, Smith EG, Banerjee A, Smith RM, Dale J, et al. (2007) Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK. Lancet 369: 1270-1276.
3. Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, et al. (2008) Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005. Clin Infect Dis 47: 168-175.
4. Wilkins MJ, Meyerson J, Bartlett PC, Spieldenner SL, Berry DE, et al. (2008) Human Mycobacterium bovis infection and bovine tuberculosis outbreak, Michigan, 1994-2007. Emerg Infect Dis 14: 657-660.
5. Zinsstag J, Schelling E, Roth F, Kazwala R (2006) Economics of bovine tuberculosis. In: Thoen CO, Steele JH, Gilsdorf MJ, eds (2006) Mycobacterium bovis infection in animals and humans. Boston, MA: Blackwell Publishing. pp 68-83.
6. Mackay CR, Hein WR (1989) A large proportion of bovine T cells express the gamma delta T cell receptor and show a distinct tissue distribution and surface phenotype. Int Immunol 1: 540-545.
7. Munroe FA, Dohoo IR, McNab WB (2000) Estimates of within-herd incidence rates of Mycobacterium bovis in Canadian cattle and cervids between 1985 and 1994. Prev Vet Med 45: 247-256.
8. Thoen CO, Barletta BR (2006) Pathogenesis of Mycobacterium bovis. In: Thoen CO, Steele JH, Gilsdorf MJ, eds (2006) Mycobacterium bovis Infection in Animals and Humans. 2nd ed. Boston, MA: Blackwell publishing. pp 18-33.
9. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099-1104.
10. Palmer MV, Waters WR, Thacker TC (2007) Lesion development and immunohistochemical changes in granulomas from cattle experimentally infected with Mycobacterium bovis. Vet Pathol 44: 863-874.
11. Song X, Bandow J, Sherman J, Baker JD, Brown PW, et al. (2008) iTRAQ Experimental Design for Plasma Biomarker Discovery. J Proteome Res.
12. Gomme PT, Bertolini J (2004) Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 22: 340-345.
13. Daiger SP, Schanfield MS, Cavalli-Sforza LL (1975) Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci U S A 72: 2076-2080.
14. Kisker O, Onizuka S, Becker CM, Fannon M, Flynn E, et al. (2003) Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia 5: 32-40.
15. Yamamoto N, Naraparaju VR (1996) Role of vitamin D3-binding protein in activation of mouse macrophages. J Immunol 157: 1744-1749.
16. Zasloff M (2006) Fighting infections with vitamin D. Nat Med 12: 388-390.
17. Liu PT, Krutzik SR, Modlin RL (2007) Therapeutic implications of the TLR and VDR partnership. Trends Mol Med 13: 117-124.
18. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
19. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75: 39-48.
20. Grange JM, Kardjito T, Setiabudi I (1984) A study of acute-phase reactant proteins in Indonesian patients with pulmonary tuberculosis. Tubercle 65: 23-39.
21. Wong CT, Saha N (1989) Serum immunoglobulin and acute phase protein concentrations in pulmonary tuberculosis patients in Singapore. Trop Geogr Med 41: 218-221.
22. Ceciliani F, Pocacqua V, Miranda-Ribera A, Bronzo V, Lecchi C, et al. (2007) alpha(1)-Acid glycoprotein modulates apoptosis in bovine monocytes. Vet Immunol Immunopathol 116: 145-152.
23. Chan ED, Kaminska AM, Gill W, Chmura K, Feldman NE, et al. (2007) Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scand J Infect Dis 39: 690-696.
24. Desvergne B (2007) Retinaldehyde: more than meets the eye. Nat Med 13: 671-673.
25. Peterson PA (1971) Characteristics of a vitamin A-transporting protein complex occurring in human serum. J Biol Chem 246: 34-43.
26. Crowle AJ, Ross EJ (1989) Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 57: 840-844.
27. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, et al. (2006) Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368: 1012-1021.
28. Shen Y, Tolic N, Masselon C, Pasa-Tolic L, Camp DG 2nd, et al. (2004) Ultrasensitive proteomics using high-efficiency on-line micro-SPE-nanoLC-nanoESI MS and MS/MS. Anal Chem 76: 144-154.
29. Trauger SA, Go EP, Shen Z, Apon JV, Compton BJ, et al. (2004) High sensitivity and analyte capture with desorption/ionization mass spectrometry on silylated porous silicon. Anal Chem 76: 4484-4489.
30. Palmer MV, Waters WR, Thacker TC, Greenwald R, Esfandiari J, et al. (2006) Effects of different tuberculin skin-testing regimens on gamma interferon and antibody responses in cattle experimentally infected with Mycobacterium bovis. Clin Vaccine Immunol 13: 387-394.
31. Li L, Bannantine JP, Zhang Q, Amonsin A, May BJ, et al. (2005) The complete genome sequence of Mycobacterium avium subspecies paratuberculosis. Proc Natl Acad Sci U S A 102: 12344-12349.
32. Stabel JR, Palmer MV, Robbe-Austerman S, Harris B (2007) Pathogenesis of Mycobacterium avium subsp. paratuberculosis in neonatal calves after oral or intraperitoneal experimental infection. 9th International Colloquium on Paratuberculosis. Tsukuba, Japan: ICP. pp 50-53.
33. Palmer MV, Waters WR, Whipple DL (2002) Aerosol delivery of virulent Mycobacterium bovis to cattle. Tuberculosis (Edinb) 82: 275-282.
34. Nelsestuen GL, Zhang Y, Martinez MB, Key NS, Jilma B, et al. (2005) Plasma protein profiling: unique and stable features of individuals. Proteomics 5: 4012-4024.